The Division of Cardiac Surgery is internationally respected by other heart experts for participating in, and leading, clinical trials that advance surgical treatment of heart disease and provide options for patients for whom traditional surgical solutions are not an option.
The Division was selected to join the Cardiothoracic Surgical Trials Network, a National Heart, Lung, and Blood Institute-supported consortium of cardiac surgery centers, to evaluate new surgical techniques, technologies, devices and innovative pharmaceutical and bioengineered products directed at improving adult cardiovascular outcomes.
Types of clinical trials at the University of Maryland include:
- New minimally invasive techniques for patients deemed too high-risk for traditional surgery
- Investigation of new ventricular assist devices
- New approaches for valve procedures, including transapical and catheter-based surgeries
Read about the COAPT clinical trial for patients with mitral valve regurgitation.
This page was last updated: September 18, 2014